ClinicalTrials.Veeva

Menu

VR Stimulation of Exercise Response in Sedentary Humans

Wayne State University logo

Wayne State University

Status

Enrolling

Conditions

Prolonged Inactivity
Metabolic Syndrome

Treatments

Behavioral: 20 minutes cycling exercise
Behavioral: Virtual Reality

Study type

Interventional

Funder types

Other
NIH

Identifiers

NCT07296991
IRB-23-06-5927
5R01AG059683-07 (U.S. NIH Grant/Contract)

Details and patient eligibility

About

Prolonged sedentary conditions contribute to declining health across human populations and cause significant secondary health consequences for many patients whose illnesses or injuries prevent them from exercising. The investigators have demonstrated that in a small animal fruit fly model, genetic stimulation of neurons that promote adrenergic signaling is sufficient to mimic the benefits of exercise training even in sedentary animals. The investigator's pilot work in humans has confirmed that humans respond to Virtual Reality (VR) stimuli that mimic exercise by increasing heart rate and altering heart rate variability in a way consistent with increased adrenergic activity.

In this study, the investigators will directly test for the first time whether repeated, controlled exposure to VR stimuli that induce adrenergic activity in sedentary humans can produce adaptive changes to protein expression and endurance performance like those produced by actual exercise in pre-diabetic participants with/without hypertension.

Enrollment

48 estimated patients

Sex

All

Ages

25 to 40 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Equal numbers male and female (32 each)
  2. Blood glucose HbA1C: 5.7-6.4% or 100-125 mg/dL
  3. BP: systolic<120 and diastolic<80 mmHg, systolic 120-129 mmHg and diastolic <80 mmHg, or systolic >130 mmHg and diastolic >80 mmHg

Exclusion criteria

  1. BMI>35kg/m2
  2. Currently involved in an exercise program or similar activity
  3. Taking medications that could affect results, including beta-blockers or SSRIs
  4. Demonstrate any form of discomfort with the VR experience through self-reported feelings of anxiety or nausea
  5. Alcohol consumption above a minimal level(<2 oz/night)
  6. BP: Systolic >160 mmHg and Diastolic >110 mmHg

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

48 participants in 3 patient groups

EX-20 minutes sub max cycling exercise
Active Comparator group
Description:
20 minutes cycling exercise
Treatment:
Behavioral: 20 minutes cycling exercise
VR-virtual reality exercise
Experimental group
Description:
20 minutes virtual cycling
Treatment:
Behavioral: Virtual Reality
VR+: 20 minutes sub max cycling exercise + virtual reality
Active Comparator group
Description:
20 minutes cycling exercise + 20 minutes virtual cycling
Treatment:
Behavioral: Virtual Reality
Behavioral: 20 minutes cycling exercise

Trial contacts and locations

1

Loading...

Central trial contact

Alyson Sujkowski, PhD; Robert J Wessells, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems